Raltitrexed
Liver Metastasis
Zhejiang UniversitySmall moleculePhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
16 Active assets in the Liver Metastasis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Calcium folinate pentahydrate National Taiwan University Hospital | Phase 3 | BB |
Eloxatin Tianjin Medical University Cancer Institute and Hospital | Phase 3 | BB |
FLUOROURACILUM National Taiwan University Hospital | Phase 3 | BB |
Talaporfin Light Sciences LLC | Phase 2 | BB |
Irinotecan Tianjin Medical University Cancer Institute and Hospital | Phase 3 | B |
View all 30 →
Same molecule, other indications
Raltitrexed is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →